| PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.35 |
Evidence |
|
| ASCL2 |
ASCL2: Achaete-scute homolog 2 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.35 |
Evidence |
|
| ZNF397 |
ZNF397, ZNF47, ZSCAN15: Zinc finger protein 397 |
ZNF221 |
ZNF221: Zinc finger protein 221 |
2.35 |
Evidence |
|
| ZNF397 |
ZNF397, ZNF47, ZSCAN15: Zinc finger protein 397 |
ZNF167 |
ZNF167, ZKSCAN7, ZNF448, ZNF64: Zinc finger protein 167 |
2.35 |
Evidence |
|
| NALP13 |
NLRP13, NALP13, NOD14: NACHT, LRR and PYD domains-containing protein 13 |
NFKB1 |
IPI00292537 |
2.35 |
Evidence |
|
| COPS6 |
COPS6, CSN6, HVIP: COP9 signalosome complex subunit 6 |
COPS7A |
COPS7A, CSN7A, DERP10: COP9 signalosome complex subunit 7a |
2.35 |
Evidence |
|
| ZNF509 |
ZNF509: Zinc finger protein 509 |
ZNF397 |
ZNF397, ZNF47, ZSCAN15: Zinc finger protein 397 |
2.35 |
Evidence |
|
| TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.35 |
Evidence |
|
| SIM2 |
SIM2: Single-minded homolog 2 |
HES2 |
HES2: Transcription factor HES-2 |
2.35 |
Evidence |
|
| SHC2 |
IPI00401979 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
2.35 |
Evidence |
|
| NALP6 |
NLRP6, NALP6, PYPAF5: NACHT, LRR and PYD domains-containing protein 6 |
NFKB1 |
IPI00292537 |
2.35 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
SHC2 |
IPI00401979 |
2.35 |
Evidence |
|
| ZNF42 |
MZF1, MZF, ZNF42, ZSCAN6: Myeloid zinc finger 1 |
KIAA1559 |
ZFP14, KIAA1559, ZNF531: Zinc finger protein 14 homolog |
2.35 |
Evidence |
|
| TFE3 |
TFE3: Transcription factor E3 |
TFEC |
TFEC, Tfec, tcag7.74: TFEC isoform |
2.35 |
Evidence |
O
|
| ZNF18 |
ZNF18, HDSG1, KOX11, ZKSCAN6: Zinc finger protein 18 |
ZNF91 |
ZNF91: Zinc finger protein 91 |
2.35 |
Evidence |
|
| ZNF18 |
ZNF18, HDSG1, KOX11, ZKSCAN6: Zinc finger protein 18 |
ZNF157 |
ZNF157: Zinc finger protein 157 |
2.35 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.35 |
Evidence |
|
| LYL1 |
LYL1: Protein lyl-1 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.35 |
Evidence |
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.35 |
Evidence |
|
| CACNA1H |
CACNA1H: Voltage-dependent T-type calcium channel subunit alpha-1H |
CACNA1F |
CACNA1F: Uncharacterized protein CACNA1F |
2.35 |
Evidence |
|
| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
COPS7A |
COPS7A, CSN7A, DERP10: COP9 signalosome complex subunit 7a |
2.35 |
Evidence |
|
| RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
MAPT |
IPI00217976 |
2.345 |
Evidence |
|
| TRIP12 |
TRIP12, KIAA0045: Probable E3 ubiquitin-protein ligase TRIP12 |
RAD18 |
RAD18, RNF73: E3 ubiquitin-protein ligase RAD18 |
2.345 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
ACP1 |
ACP1: Low molecular weight phosphotyrosine protein phosphatase |
2.345 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
2.345 |
Evidence |
|